{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:57:26Z","timestamp":1767992246322,"version":"3.49.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11908-015-0513-6","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T08:56:56Z","timestamp":1453971416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Infection Prevention in Transplantation"],"prefix":"10.1007","volume":"18","author":[{"given":"Steven A.","family":"Pergam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"key":"513_CR1","doi-asserted-by":"publisher","unstructured":"Swartling L, Allard A, Torlen J, Ljungman P, Mattsson J, Sparrelid E. Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2015. doi: 10.1111\/tid.12443.","DOI":"10.1111\/tid.12443"},{"key":"513_CR2","doi-asserted-by":"publisher","unstructured":"Team RSVOI. Contributing and terminating factors of a large RSV outbreak in an adult hematology and transplant unit. PLoS Currents. 2014;6. doi: 10.1371\/currents.outbreaks.3bc85b2a508d205ecc4a5534ecb1f9be. A review that addresses major risk factors for respiratory virus outbreaks in transplant units and methods used to limit outbreak.","DOI":"10.1371\/currents.outbreaks.3bc85b2a508d205ecc4a5534ecb1f9be"},{"key":"513_CR3","unstructured":"Rutala WA, Weber DJ. Guideline for disinfection and sterilization in healthcare facilities, 2008. Healthcare Infection Control Advisory Committee. Downloaded from www.cdc.gov September 10, 2015."},{"issue":"5","key":"513_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/670222","volume":"34","author":"PC Carling","year":"2013","unstructured":"Carling PC, Huang SS. Improving healthcare environmental cleaning and disinfection: current and evolving issues. Infect Control Hosp Epidemiol. 2013;34(5):507\u201313.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"513_CR5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/ajt.12784","volume":"14","author":"PD Ziakas","year":"2014","unstructured":"Ziakas PD, Pliakos EE, Zervou FN, Knoll BM, Rice LB, Mylonakis E. MRSA and VRE colonization in solid organ transplantation: a meta-analysis of published studies. Am J Transplant. 2014;14(8):1887\u201394. An important review of major publications regarding MRSA and VRE in solid organ transplant patients that addresses both screening and risk of complications.","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"513_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/ajt.12098","volume":"13","author":"C Garzoni","year":"2013","unstructured":"Garzoni C, Vergidis P. Practice ASTIDCo. Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:50\u20138. Current American Society of Transplant Guidelines for MRSA and VRE.","journal-title":"Am J Transplant"},{"issue":"5","key":"513_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3904\/kjim.2015.30.5.694","volume":"30","author":"YJ Kim","year":"2015","unstructured":"Kim YJ, Kim SI, Choi JY, Yoon SK, You YK, Kim DG. Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients. Korean J Intern Med. 2015;30(5):694\u2013704.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"513_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1086\/500651","volume":"27","author":"N Singh","year":"2006","unstructured":"Singh N, Squier C, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV. Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients. Infect Control Hosp Epidemiol. 2006;27(2):122\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"513_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10096-013-2046-y","volume":"33","author":"CJ Clancy","year":"2014","unstructured":"Clancy CJ, Bartsch SM, Nguyen MH, Stuckey DR, Shields RK, Lee BY. A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients. Eur J Clin Microbiol Infect Dis. 2014;33(6):1053\u201361. An interesting simulation model based on clinical data that suggests that MRSA screening and decolonization may be cost effective in high-risk transplant patients.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"513_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajic.2014.10.010","volume":"43","author":"A Miles-Jay","year":"2015","unstructured":"Miles-Jay A, Podczervinski S, Stednick ZJ, Pergam SA. Evaluation of routine pretransplantation screening for methicillin-resistant Staphyloscoccus aureus in hematopoietic cell transplant recipients. Am J Infect Control. 2015;43(1):89\u201391. Review of MRSA surveillance prior to HCT suggesting limited benefits to nasal cultures performed pre-transplant.","journal-title":"Am J Infect Control"},{"issue":"10","key":"513_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/sj.bmt.1705654","volume":"39","author":"BE Shaw","year":"2007","unstructured":"Shaw BE, Boswell T, Byrne JL, Yates C, Russell NH. Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. Bone Marrow Transplant. 2007;39(10):623\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"513_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/cid\/cis550","volume":"55","author":"J Vydra","year":"2012","unstructured":"Vydra J, Shanley RM, George I, et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55(6):764\u201370.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"513_CR13","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.bbmt.2010.05.008","volume":"16","author":"M Kamboj","year":"2010","unstructured":"Kamboj M, Chung D, Seo SK, et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010;16(11):1576\u201381.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"513_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15(10):1143\u2013238.","journal-title":"Biol Blood Marrow Transplant"},{"key":"513_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2015.208","volume":"36","author":"RF Chemaly","year":"2015","unstructured":"Chemaly RF, Ghantoji SS, Huber T, Raad II, Jinadatha C, Stibich M. Innovative analysis of the sequenced patterns of vancomycin-resistant enterococci strains to determine clonal transmission in a hospital setting. Infect Control Hosp Epidemiol. 2015;36:1\u20133. Novel approach to sequencing of VRE in transplant unit that presents molecular evidence of nosocomial transmission.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"513_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1086\/659408","volume":"32","author":"NG Almyroudis","year":"2011","unstructured":"Almyroudis NG, Lesse AJ, Hahn T, et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2011;32(5):490\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"513_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/2047-2994-3-37","volume":"3","author":"E Short","year":"2014","unstructured":"Short E, Esterly J, Postelnick M, Ong J, McLaughlin M. Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization. Antimicrobial Resistance and Infection Control. 2014;3(1):37. Important study suggesting that surveillance for VRE increases inappropriate use of Linezolid and Daptomycin.","journal-title":"Antimicrobial Resistance and Infection Control"},{"issue":"7","key":"513_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.clinthera.2015.04.008","volume":"37","author":"PA Moise","year":"2015","unstructured":"Moise PA, Sakoulas G, McKinnell JA, et al. Clinical outcomes of daptomycin for vancomycin-resistant Enterococcus bacteremia. Clin Ther. 2015;37(7):1443\u201353. e1442.","journal-title":"Clin Ther"},{"key":"513_CR19","doi-asserted-by":"publisher","unstructured":"Niebel M, Perera MT, Shah T, et al. Emergence of linezolid resistance in hepatobiliary infections caused by Enterococcus faecium. Liver Transpl. 2015.\u00a0doi: 10.1002\/lt.24328.","DOI":"10.1002\/lt.24328"},{"issue":"Pt 2","key":"513_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1099\/jmm.0.000004","volume":"64","author":"SS Ghantoji","year":"2015","unstructured":"Ghantoji SS, Stibich M, Stachowiak J, et al. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. J Med Microbiol. 2015;64(Pt 2):191\u20134.","journal-title":"J Med Microbiol"},{"key":"513_CR21","doi-asserted-by":"crossref","unstructured":"Miller R, Simmons S, Dale C, Stibich M, Stachowiak J. Utilization and impact of a pulsed-xenon ultraviolet room disinfection system and multidisciplinary care team on Clostridium difficile in a long-term acute care facility. Am J Infect Control. 2015;43(12):1350\u20133.","DOI":"10.1016\/j.ajic.2015.07.029"},{"issue":"5","key":"513_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/cid\/ciu880","volume":"60","author":"IA Echenique","year":"2015","unstructured":"Echenique IA, Penugonda S, Stosor V, Ison MG, Angarone MP. Diagnostic yields in solid organ transplant recipients admitted with diarrhea. Clin Infect Dis. 2015;60(5):729\u201337. Study demonstrating both the frequency and infectious etiologies for diarrhea in solid organ transplant patients. Demonstrates the importance of norovirus as a major pathogen in these patients.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"513_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1399-3062.2007.00230.x","volume":"9","author":"M Kamboj","year":"2007","unstructured":"Kamboj M, Mihu CN, Sepkowitz K, Kernan NA, Papanicolaou GA. Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield. Transpl Infect Dis. 2007;9(4):265\u20139.","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"513_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124483","volume":"10","author":"S Paudel","year":"2015","unstructured":"Paudel S, Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E. Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies. PLoS One. 2015;10(4), e0124483. Gives important epidemiologic data on rates of C. difficile from multiple centers and studies.","journal-title":"PLoS One"},{"key":"513_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13756-015-0081-4","volume":"4","author":"NM Boyle","year":"2015","unstructured":"Boyle NM, Magaret A, Stednick Z, et al. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrobial Resistance & Infection Control. 2015;4:41. A large study that address rates of C.difficile in pediatric and adult HCT recipients, and demonstrates both the high frequency of testing and increased risk for pediatric patients.","journal-title":"Antimicrobial Resistance & Infection Control"},{"issue":"9","key":"513_CR26","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.bbmt.2014.04.026","volume":"20","author":"J Bruminhent","year":"2014","unstructured":"Bruminhent J, Wang ZX, Hu C, et al. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(9):1329\u201334. A large study demonstrating the high-risk of C.difficile colonization in HCT recipients.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"513_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090158","volume":"9","author":"MA Kinnebrew","year":"2014","unstructured":"Kinnebrew MA, Lee YJ, Jenq RR, et al. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One. 2014;9(3), e90158. Prospective data that demonstrates the rate of pre-transplant colonization, but also the frequency of early post-transplant events.","journal-title":"PLoS One"},{"key":"513_CR28","doi-asserted-by":"crossref","unstructured":"Jain T, Croswell C, Urday-Cornejo V, et al. Clostridium difficile colonization in hematopoietic stem cell transplant recipients: a prospective study of the epidemiology and outcomes involving toxigenic and nontoxigenic strains. Biol Blood Marrow Transplant. 2016;22(1):157-63. A study which suggests that non-toxigenic strains of C. difficle may protect against developing toxigenic strains.","DOI":"10.1016\/j.bbmt.2015.07.020"},{"issue":"2","key":"513_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ajt.12577","volume":"14","author":"RJ Friedman-Moraco","year":"2014","unstructured":"Friedman-Moraco RJ, Mehta AK, Lyon GM, Kraft CS. Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients. Am J Transplant. 2014;14(2):477\u201380. A review of fecal microbiota transplants in solid organ transplant patients. Discusses potential risks and currently available data.","journal-title":"Am J Transplant"},{"issue":"8","key":"513_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134737","volume":"10","author":"MJ Espinar","year":"2015","unstructured":"Espinar MJ, Miranda IM, Costa-de-Oliveira S, Rocha R, Rodrigues AG, Pina-Vaz C. Urinary tract infections in kidney transplant patients due to Escherichia coli and Klebsiella pneumoniae-producing extended-spectrum beta-lactamases: risk factors and molecular epidemiology. PLoS One. 2015;10(8), e0134737.","journal-title":"PLoS One"},{"issue":"6","key":"513_CR31","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.transproceed.2014.05.003","volume":"46","author":"EB Aguiar","year":"2014","unstructured":"Aguiar EB, Maciel LC, Halpern M, et al. Outcome of bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae after solid organ transplantation. Transplant Proc. 2014;46(6):1753\u20136. Important review that addresses complications and mortality risk from ESBL pathogens.","journal-title":"Transplant Proc"},{"issue":"4","key":"513_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/ajt.13075","volume":"15","author":"M Bodro","year":"2015","unstructured":"Bodro M, Sanclemente G, Lipperheide I, et al. Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients. Am J Transplant. 2015;15(4):1021\u20137.","journal-title":"Am J Transplant"},{"issue":"9","key":"513_CR33","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/cid\/ciu052","volume":"58","author":"MJ Satlin","year":"2014","unstructured":"Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):1274\u201383. A review of issues surrounding CRE in high risk transplant patients. Discusses strategies for treatment and prevention.","journal-title":"Clin Infect Dis"},{"key":"513_CR34","doi-asserted-by":"publisher","unstructured":"Pereira MR, Scully BF, Pouch SM, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015. doi: 10.1002\/lt.24207.","DOI":"10.1002\/lt.24207"},{"issue":"4","key":"513_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123706","volume":"10","author":"S Lanini","year":"2015","unstructured":"Lanini S, Costa AN, Puro V, et al. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study. PLoS One. 2015;10(4), e0123706.","journal-title":"PLoS One"},{"issue":"10","key":"513_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139883","volume":"10","author":"P Torres-Gonzalez","year":"2015","unstructured":"Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, et al. Factors associated to prevalence and incidence of carbapenem-resistant Enterobacteriaceae fecal carriage: a cohort study in a Mexican tertiary care hospital. PLoS One. 2015;10(10), e0139883.","journal-title":"PLoS One"},{"issue":"1","key":"513_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085210","volume":"9","author":"Y Chong","year":"2014","unstructured":"Chong Y, Shimoda S, Yakushiji H, et al. Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis. PLoS One. 2014;9(1), e85210.","journal-title":"PLoS One"},{"issue":"1","key":"513_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/tid.12169","volume":"16","author":"F Bert","year":"2014","unstructured":"Bert F, Larroque B, Dondero F, et al. Risk factors associated with preoperative fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transpl Infect Dis. 2014;16(1):84\u20139. Review of risk-factors for ESBL and value of pre-transplant screening in liver transplant patients. One of few studies to address screening for ESBL in this population.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"513_CR39","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/ajt.13227","volume":"15","author":"X Ye","year":"2015","unstructured":"Ye X, Van JN, Munoz FM, et al. Noroviruses as a cause of diarrhea in immunocompromised pediatric hematopoietic stem cell and solid organ transplant recipients. Am J Transplant. 2015;15(7):1874\u201381.","journal-title":"Am J Transplant"},{"issue":"10","key":"513_CR40","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.ajic.2015.05.032","volume":"43","author":"A Sheahan","year":"2015","unstructured":"Sheahan A, Copeland G, Richardson L, et al. Control of norovirus outbreak on a pediatric oncology unit. Am J Infect Control. 2015;43(10):1066\u20139. A recent review of an outbreak of norovirus in a transplant center. Discusses important methods for control of outbreak that are highly relevant for other centers dealing with similar situations.","journal-title":"Am J Infect Control"},{"issue":"3","key":"513_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jcv.2014.08.004","volume":"61","author":"LG Lemes","year":"2014","unstructured":"Lemes LG, Correa TS, Fiaccadori FS, et al. Prospective study on Norovirus infection among allogeneic stem cell transplant recipients: prolonged viral excretion and viral RNA in the blood. J Clin Virol. 2014;61(3):329\u201333.","journal-title":"J Clin Virol"},{"issue":"4","key":"513_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jcv.2014.01.004","volume":"59","author":"L Owen","year":"2014","unstructured":"Owen L, Jones G, Despott EJ, et al. Fatal enteritis in a renal transplant patient with post-transplant thrombotic microangiopathy undergoing plasma exchange therapy. J Clin Virol. 2014;59(4):213\u20137.","journal-title":"J Clin Virol"},{"issue":"4","key":"513_CR43","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbmt.2015.01.009","volume":"21","author":"J van Montfrans","year":"2015","unstructured":"van Montfrans J, Schulz L, Versluys B, et al. Viral PCR positivity in stool before allogeneic hematopoietic cell transplantation is strongly associated with acute intestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(4):772\u20134. An interesting study that suggests that viral GI pathogens detected pre-transplant may play a role in the development of post-transplant GVHD. Has implications for pre-transplant screening and prevention strategies.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"24","key":"513_CR44","doi-asserted-by":"publisher","first-page":"14184","DOI":"10.1128\/JVI.02494-14","volume":"88","author":"E Vega","year":"2014","unstructured":"Vega E, Donaldson E, Huynh J, et al. RNA populations in immunocompromised patients as reservoirs for novel norovirus variants. J Virol. 2014;88(24):14184\u201396.","journal-title":"J Virol"},{"issue":"6","key":"513_CR45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/cid\/ciu940","volume":"60","author":"JR Brown","year":"2015","unstructured":"Brown JR, Morfopoulou S, Hubb J, et al. Astrovirus VA1\/HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patients. Clin Infect Dis. 2015;60(6):881\u20138.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"513_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027483","volume":"6","author":"W Wunderli","year":"2011","unstructured":"Wunderli W, Meerbach A, Gungor T, et al. Astrovirus infection in hospitalized infants with severe combined immunodeficiency after allogeneic hematopoietic stem cell transplantation. PLoS One. 2011;6(11), e27483.","journal-title":"PLoS One"},{"issue":"9","key":"513_CR47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.7326\/M15-0447","volume":"162","author":"NA Halsey","year":"2015","unstructured":"Halsey NA, Salmon DA. Measles at Disneyland, a problem for all ages. Ann Intern Med. 2015;162(9):655\u20136.","journal-title":"Ann Intern Med"},{"issue":"48","key":"513_CR48","first-page":"1129","volume":"63","author":"K Winter","year":"2014","unstructured":"Winter K, Glaser C, Watt J, Harriman K. Centers for Disease C, Prevention. Pertussis epidemic\u2014California, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(48):1129\u201332.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"513_CR49","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44\u2013e100. Guidelines for vaccination in immunosuppressed hosts from IDSA.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"513_CR50","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.vaccine.2015.01.075","volume":"33","author":"Y Kawano","year":"2015","unstructured":"Kawano Y, Suzuki M, Kawada J, et al. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine. 2015;33(12):1440\u20135.","journal-title":"Vaccine"},{"key":"513_CR51","doi-asserted-by":"crossref","unstructured":"Shah GL, Shune L, Purtill D, et al. Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies. Biol Blood Marrow Transplant. 2015;21(12):2160\u20136.","DOI":"10.1016\/j.bbmt.2015.08.010"},{"key":"513_CR52","unstructured":"Advisory Committee on Immunization Practices, Centers for Disease Control. Recommended adult immunization schedule\u2014United States\u20142015. Downloaded from http:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/adult\/adult-combined-schedule.pdf October 25, 2015."},{"key":"513_CR53","unstructured":"Advisory Committee on Immunization Practices, Centers for Disease Control. Recommended immunization schedules for persons aged 0 through 18 years\u2014United States, 2015. Downloaded from http:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf October 25, 2015."},{"issue":"7","key":"513_CR54","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1182\/blood-2009-11-255455","volume":"115","author":"C Casper","year":"2010","unstructured":"Casper C, Englund J, Boeckh M. How I treat influenza in patients with hematologic malignancies. Blood. 2010;115(7):1331\u201342.","journal-title":"Blood"},{"issue":"1","key":"513_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ajt.13093","volume":"15","author":"DR Kaul","year":"2015","unstructured":"Kaul DR, Mehta AK, Wolfe CR, Blumberg E, Green M. Ebola virus disease: implications for solid organ transplantation. Am J Transplant. 2015;15(1):5\u20136.","journal-title":"Am J Transplant"},{"issue":"4","key":"513_CR56","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/ajt.13085","volume":"15","author":"M AlGhamdi","year":"2015","unstructured":"AlGhamdi M, Mushtaq F, Awn N, Shalhoub S. MERS CoV infection in two renal transplant recipients: case report. Am J Transplant. 2015;15(4):1101\u20134.","journal-title":"Am J Transplant"},{"issue":"11","key":"513_CR57","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1182\/blood-2014-12-616516","volume":"125","author":"A Waghmare","year":"2015","unstructured":"Waghmare A, Pergam SA, Jerome KR, Englund JA, Boeckh M, Kuypers J. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients. Blood. 2015;125(11):1724\u20139.","journal-title":"Blood"},{"issue":"Suppl 5","key":"513_CR58","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.1093\/cid\/ciu639","volume":"59","author":"JR Perfect","year":"2014","unstructured":"Perfect JR, Hachem R, Wingard JR. Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients. Clin Infect Dis. 2014;59 Suppl 5:S352\u20135. Up to date review of fungal infections in high-risk hosts. Addresses prevention and prophylaxis strategies.","journal-title":"Clin Infect Dis"},{"key":"513_CR59","doi-asserted-by":"publisher","unstructured":"Libbrecht C, Goutagny MP, Bacchetta J, et al. Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing hematopoietic stem cell transplantation. Eur J Haematol. 2015. doi: 10.1111\/ejh.12685.","DOI":"10.1111\/ejh.12685"},{"key":"513_CR60","doi-asserted-by":"crossref","unstructured":"Picot-Gueraud R, Khouri C, Brenier-Pinchart MP, et al. En-suite bathrooms in protected haematology wards: a source of filamentous fungal contamination? J Hosp Infect. 2015;91(3):244-9","DOI":"10.1016\/j.jhin.2015.07.005"},{"issue":"3","key":"513_CR61","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/cid\/civ297","volume":"61","author":"H Kanamori","year":"2015","unstructured":"Kanamori H, Rutala WA, Sickbert-Bennett EE, Weber DJ. Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation. Clin Infect Dis. 2015;61(3):433\u201344. A comprehensive review of fungal outbreeaks linked to healthcare settings. Critical for infection preventionists in dealing with new construction in their institutions.","journal-title":"Clin Infect Dis"},{"key":"513_CR62","unstructured":"Facility Guidelines Institute. Guidelines for design and construction of hospitals and outpatient facilities. Chicago: American Society for Healthcare Engineering of the American Hospital Association; 2014. http:\/\/www.fgiguidelines.org\/guidelines2014_HOP.php Accessed Ocotober 2015."},{"issue":"2","key":"513_CR63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/pbc.24685","volume":"61","author":"HR Pokala","year":"2014","unstructured":"Pokala HR, Leonard D, Cox J, et al. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia. Pediatr Blood Cancer. 2014;61(2):276\u201380.","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 5","key":"513_CR64","doi-asserted-by":"publisher","first-page":"S344","DOI":"10.1093\/cid\/ciu623","volume":"59","author":"RF Chemaly","year":"2014","unstructured":"Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;59 Suppl 5:S344\u201351. An excellent up-to-date review of the diagnostics, prevention and treatment of respiratory viruses in HCT recipients.","journal-title":"Clin Infect Dis"},{"key":"513_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10428194.2015.1067699","volume":"2","author":"A Hoellein","year":"2015","unstructured":"Hoellein A, Hecker J, Hoffmann D, et al. Serious outbreak of human metapneumovirus in patients with hematologic malignancies. Leuk Lymphoma. 2015;2:1\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"513_CR66","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.bbmt.2014.02.024","volume":"20","author":"HY Chu","year":"2014","unstructured":"Chu HY, Englund JA, Podczervinski S, et al. Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center. Biol Blood Marrow Transplant. 2014;20(6):844\u201351. A review of two large outbreaks of RSV in HCT recipients. Describes in detail methods for prevention and infection control practice to prevent transmission events.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"513_CR67","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/cid\/civ272","volume":"61","author":"AP Campbell","year":"2015","unstructured":"Campbell AP, Guthrie KA, Englund JA, et al. Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin Infect Dis. 2015;61(2):192\u2013202. Discusses the risk of pre-transplant respiratory viral infections, and stresses the importance of early identification and infection prevention methods for preventing transmission.","journal-title":"Clin Infect Dis"},{"key":"513_CR68","doi-asserted-by":"crossref","unstructured":"Sung AD, Sung JA, Corbert K, Lan L, Broadwater G, et. al. Surgical mask usage reduces the incidence of parainfleunza virus 3 in recipients of stem cell transplantation. Presented at The American Society of Blood and Marrow Trasnplantation; Salt Lake City. 2013; Abstract 321.","DOI":"10.1016\/j.bbmt.2012.11.375"},{"issue":"9","key":"513_CR69","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1111\/ajt.13285","volume":"15","author":"I Helantera","year":"2015","unstructured":"Helantera I, Anttila VJ, Lappalainen M, Lempinen M, Isoniemi H. Outbreak of influenza A(H1N1) in a kidney transplant unit-protective effect of vaccination. Am J Transplant. 2015;15(9):2470\u20134.","journal-title":"Am J Transplant"},{"issue":"3","key":"513_CR70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajic.2014.11.025","volume":"43","author":"S Podczervinski","year":"2015","unstructured":"Podczervinski S, Stednick Z, Helbert L, et al. Employee influenza vaccination in a large cancer center with high baseline compliance rates: comparison of carrot versus stick approaches. Am J Infect Control. 2015;43(3):228\u201333.","journal-title":"Am J Infect Control"},{"issue":"9","key":"513_CR71","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jamapediatrics.2015.0684","volume":"169","author":"JE Szymczak","year":"2015","unstructured":"Szymczak JE, Smathers S, Hoegg C, Klieger S, Coffin SE, Sammons JS. Reasons why physicians and advanced practice clinicians work while sick: a mixed-methods analysis. JAMA Pediatrics. 2015;169(9):815\u201321.","journal-title":"JAMA Pediatrics"},{"issue":"4","key":"513_CR72","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/tid.12399","volume":"17","author":"E Snarski","year":"2015","unstructured":"Snarski E, Mank A, Iacobelli S, et al. Current practices used for the prevention of central venous catheter-associated infection in hematopoietic stem cell transplantation recipients: a survey from the Infectious Diseases Working Party and Nurses\u2019 Group of EBMT. Transpl Infect Dis. 2015;17(4):558\u201365.","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"513_CR73","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa1113849","volume":"368","author":"MW Climo","year":"2013","unstructured":"Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013;368(6):533\u201342. A large randomized clinical trial that demonstrated the effectiveness of daily chlorhexidine bathing on HAI colonization and CLABSIs; study included HCT units which is uncommon in most large infection prevention trials.","journal-title":"N Engl J Med"},{"key":"513_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2015.219","volume":"36","author":"M Kamboj","year":"2015","unstructured":"Kamboj M, Blair R, Bell N, et al. Use of disinfection cap to reduce central-line-associated bloodstream infection and blood culture contamination among hematology-oncology patients. Infect Control Hosp Epidemiol. 2015;36:1\u20138. Intersting study that suggests that ethanol impregnated disinfection caps for central catheters can decrease CLABSI rates in high-risk immunosuppressed patients.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"513_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhin.2014.06.007","volume":"88","author":"LJ Worth","year":"2014","unstructured":"Worth LJ, Slavin MA, Heath S, Szer J, Grigg AP. Ethanol versus heparin locks for the prevention of central venous catheter-associated bloodstream infections: a randomized trial in adult haematology patients with Hickman devices. The Journal of Hospital Infection. 2014;88(1):48\u201351.","journal-title":"The Journal of Hospital Infection"},{"key":"513_CR76","unstructured":"World Health Organization. A guide to the implementation of the WHO multimodal hand hygiene improvement strategy. Accessed online at http:\/\/www.who.int\/gpsc\/5may\/Guide_to_Implementation.pdf on Sept 5, 2015."},{"issue":"5","key":"513_CR77","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ajic.2014.01.002","volume":"42","author":"MA Ward","year":"2014","unstructured":"Ward MA, Schweizer ML, Polgreen PM, Gupta K, Reisinger HS, Perencevich EN. Automated and electronically assisted hand hygiene monitoring systems: a systematic review. Am J Infect Control. 2014;42(5):472\u20138.","journal-title":"Am J Infect Control"},{"issue":"6","key":"513_CR78","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajic.2012.09.009","volume":"41","author":"K Graf","year":"2013","unstructured":"Graf K, Ott E, Wolny M, et al. Hand hygiene compliance in transplant and other special patient groups: an observational study. Am J Infect Control. 2013;41(6):503\u20138.","journal-title":"Am J Infect Control"},{"issue":"11","key":"513_CR79","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/678419","volume":"35","author":"JA Srigley","year":"2014","unstructured":"Srigley JA, Furness CD, Gardam M. Measurement of patient hand hygiene in multiorgan transplant units using a novel technology: an observational study. Infect Control Hosp Epidemiol. 2014;35(11):1336\u201341. Study that demonstrates that transplant staff are no better than other units on washing their hands. Should provide encouragement for other centers to address hand hygiene practices in their own institutions.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"513_CR80","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jhin.2014.12.024","volume":"90","author":"VC Cheng","year":"2015","unstructured":"Cheng VC, Chau PH, Lee WM, et al. Hand-touch contact assessment of high-touch and mutual-touch surfaces among healthcare workers, patients, and visitors. The Journal of Hospital Infection. 2015;90(3):220\u20135.","journal-title":"The Journal of Hospital Infection"},{"key":"513_CR81","doi-asserted-by":"publisher","unstructured":"Birnbach DJ. Following the trail of prior research: a closer look at hand hygiene compliance by hospital visitors. Am J Infect Control. 2015. doi: 10.1016\/j.ajic.2015.05.015.","DOI":"10.1016\/j.ajic.2015.05.015"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-015-0513-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0513-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:55:13Z","timestamp":1744163713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-015-0513-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s11908-015-0513-6","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]},"assertion":[{"value":"28 January 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Pergam has served as a consultant for Merck, Optimer\/Cubist, and Chimerix, and participated in clinical trials with these three entities; all efforts have been outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"7"}}